Important questions asked by family members of intensive care unit patients*
Vincent Peigne(Centre Hospitalier Métropole Savoie), Élie Azoulay(Hôpital Saint-Louis), Nicolas Bèle, Maïté Garrouste-Orgeas(Université Paris Cité), Sylvie Chevret(Saint Louis University Hospital), Bruno Mégarbane(Hôpital Avicenne), M. Jourdain(Université de Lille), Kateřina Rusínová(Inserm), Alain Cariou(Hôpital Cochin), Nancy Kentish‐Barnes(Inserm), Fabienne Fieux(Sorbonne Université), B. Régnier(Université Claude Bernard Lyon 1), Anne Renault(Centre Hospitalier Régional Universitaire de Brest), Alexandre Lautrette(Centre Hospitalier Universitaire de Clermont-Ferrand), Jean-François Timsit(Assistance Publique – Hôpitaux de Paris), Marina Thirion, Hugues Georges(Centre Hospitalier de Tourcoing), Marine Chaize, Achille Kouatchet(Oslo University Hospital), Dany Toledano(Université Paris-Sud), Frédéric Pochard(Université Claude Bernard Lyon 1), Stéphane Legriel(Inserm), Benoı̂t Schlemmer(Université Paris Cité), Bruno Falissard(Inserm)
Cited by 70
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
|New England Journal of Medicine|2021|979
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777